Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2018
Number of items: 3.

2022

Werner, J., Wolf, L., Tscherpel, C., Bauer, E. K., Wollring, M., Ceccon, G., Deckert, M., Brunn, A., Pappesch, R., Goldbrunner, R., Fink, G. R. and Galldiks, N. (2022). EFFICACY AND TOLERABILITY OF REGORAFENIB IN PRETREATED PATIENTS WITH PROGRESSIVE CNS GRADE 3 OR 4 GLIOMAS. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

2018

Heydt, C., Pappesch, R., Rehker, J., Wagener, S., Ihle, M. A., Siemanowski, J., Buettner, R., Fassunke, J. and Merkelbach-Bruse, S. (2018). Comparison of DNA- and RNA-based parallel sequencing approaches for the detection of MET Exon 14 skipping mutations. Virchows Arch., 473. S. S288 - 1. NEW YORK: SPRINGER. ISSN 1432-2307

Heydt, C., Pappesch, R., Stecker, K., Neumann, J., Buettner, R. and Merkelbach-Bruse, S. (2018). Evaluation of the TruSight Tumor 170 (TST170) assay and its value in clinical research. Ann. Oncol., 29. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

This list was generated on Fri Apr 26 18:49:23 2024 CEST.